M&A Deal Summary

Takeda Pharmaceutical Acquires Nycomed Pharma AG

On May 19, 2011, Takeda Pharmaceutical Co.,Ltd. acquired life science company Nycomed Pharma AG from Stockwell Capital, aPriori Capital Partners, Avista Capital Partners, HarbourVest Partners and Nordic Capital for 9.6B EUR

Acquisition Highlights
  • This is Takeda Pharmaceutical’s 4th transaction in the Life Science sector.
  • This is Takeda Pharmaceutical’s 2nd largest (disclosed) transaction.
  • This is Takeda Pharmaceutical’s 1st transaction in Switzerland.

M&A Deal Summary

Date 2011-05-19
Target Nycomed Pharma AG
Sector Life Science
Buyer(s) Takeda Pharmaceutical Co.,Ltd.
Sellers(s) Stockwell Capital
aPriori Capital Partners
Avista Capital Partners
HarbourVest Partners
Nordic Capital
Deal Type Add-on Acquisition
Deal Value 9.6B EUR

Target

Nycomed Pharma AG

Zurich, Switzerland
website
Nycomed Pharma AG is a manufacturer, marketer, and promoting a range of Rx and OTC pharmaceutical products in Europe. Nycomed offers hospital products and general practitioner medicines, as well as provides late-stage clinical development, and registration and marketing. Nycomed Pharma AG was established in 1986 and is based in Zurich, Switzerland.

Search 159,180 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Takeda Pharmaceutical Co.,Ltd.

Osaka, Japan

website


Category Company
Founded 1781
SectorHealthcare Services
Employees7,495
Revenue 3,291.2B JPY (2020)
DESCRIPTION

Takeda Pharmaceutical Company Limited is a Japan-based company engaged in the pharmaceutical business. Research & Development, Manufacturing, Sales and Marketing, and Import/Export of Pharmaceutical Drugs, etc.The Company operates in three business segments,Ethical, Healthcare and others. Takeda Pharmaceutical Company was founded in 1781 and is based in Tokyo, Japan.


DEAL STATS #
Overall 4 of 14
Sector (Life Science) 4 of 13
Type (Add-on Acquisition) 4 of 13
Country (Switzerland) 1 of 1
Year (2011) 1 of 2
Size (of disclosed) 2 of 9
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2008-05-13 Millennium Pharmaceuticals, Inc.

Cambridge, Massachusetts, United States

Millennium Pharmaceuticals, Inc. is a biopharmaceutical company. Millennium research, development and commercialization activities are focused in two therapeutic areas: oncology and inflammation. By applying its knowledge of the human genome, understanding of disease mechanisms and industrialized drug discovery platform, Millennium is developing an exciting pipeline of innovative product candidates.

Buy $8.8B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2011-12-21 Intellikine, Inc.

La Jolla, California, United States

Intellikine, Inc. is a private company focused on the development of innovative, small molecule drugs targeting the PI3K/mTOR pathway for the treatment of cancer and other serious diseases.

Buy $190M

Seller(S) 5

SELLER

Stockwell Capital

Chicago, Illinois, United States

Investor Investor Investor

website


Category Private Equity Firm
Founded 2002
PE ASSETS 750M USD
SizeMiddle-Market
Type Sector Agnostic
DESCRIPTION

Stockwell Capital is a co-investment firm, focused on making minority investments alongside private equity sponsors. Stockwell is a generalist investor, with no sector preferences and looks to commit $3 to $10 million per investment. The Firm will consider opportunities throughout the US and Europe and prefers late-stage or growth equity situations. Stockwell Capital was formed in 2002 and is based in Chicago.


DEAL STATS #
Overall 10 of 37
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 3 of 12
Country (Switzerland) 1 of 1
Year (2011) 3 of 4
Size (of disclosed) 1 of 17
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-02-04 Neurotherm, Inc.

Wilmington, Massachusetts, United States

NeuroTherm, is a developer, manufacturer and provider of medical products used in interventional pain management. NeuroTherm’s products include radiofrequency (“RF”) generators and related consumable products as well as epidural catheters, discography devices, intradiscal therapies, pharmaceutical compounding and procedure tables.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2011-10-24 HIT Entertainment Ltd.

London, United Kingdom

HIT Entertainment is one of the world's leading independent children's entertainment producers and rights-owners. HIT's portfolio includes properties, such as Thomas & Friends™, Barney™, Bob the Builder™, Fireman Sam™, Angelina Ballerina™, Mike the Knight™, Pingu™ and Rainbow Magic™. Launched in 1989, HIT's lines of business span television and video production, content distribution, publishing, consumer products licensing and live events and has operations in the UK, US, Canada, Hong Kong and Japan.

Sell $680M
SELLER

aPriori Capital Partners

Investor Investor Investor

website


Category Private Equity Firm
Founded 1985
PE ASSETS 2.0B USD
SizeLarge
Type Sector Agnostic
DESCRIPTION

aPriori Capital Partners (formerly DLJ Merchant Banking Partners) is a middle-market private equity firm focused on middle-market buyouts in the US and Europe. Sectors of interest include healthcare, retail, consumer, energy, business services, and industrial. aPriori was originally established in 1985 and has offices in New York and Los Angeles.


DEAL STATS #
Overall 32 of 51
Sector (Life Science) 7 of 9
Type (Add-on Acquisition) 14 of 22
Country (Switzerland) 3 of 3
Year (2011) 2 of 4
Size (of disclosed) 1 of 21
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-02-17 NextPharma Technologies Ltd.

London, United Kingdom

NextPharma Technologies Ltd. is a pharmaceutical contract development and manufacturing organization serving worldwide markets. NextPharma provides a full range of pharmaceutical services across the entire supply chain, including pharmaceutical development, clinical trial services, analytical services, commercial manufacturing and packaging, generic dossiers, and licensing. NextPharma Technologies Ltd. was founded in 2000 and is based in London, United Kingdom.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2011-06-01 Enduring Resources II LLC

Denver, Colorado, United States

Enduring Resources II LLC is focused on pursuing a diverse portfolio of acquisition and exploitation opportunities in central onshore U.S. basins. Enduring Resources II was founded in 2011 and is based in Denver, Colorado.

Buy -
SELLER

Avista Capital Partners

New York, New York, United States

website


Category Private Equity Firm
Founded 2005
PE ASSETS 6.0B USD
SizeMega
Type Sector Focused
DESCRIPTION

Avista Capital Partners is a private investment firm formed by a group of professionals with roots from DLJ Merchant Banking Partners. Avista makes controlling and minority investments in US based energy, healthcare, and media companies with revenues greater than $25 million. Typical transactions include leverage buyouts, build-ups, and growth capital financings. Avista Capital was formed in 2005 and is based in New York City with an additional office in Houston, Texas.


DEAL STATS #
Overall 7 of 29
Sector (Life Science) 1 of 6
Type (Add-on Acquisition) 3 of 14
Country (Switzerland) 1 of 1
Year (2011) 1 of 1
Size (of disclosed) 1 of 10
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-05-12 Appalachian Midstream Partners LLC

Columbus, Ohio, United States

Appalachian Midstream Partners’ primary asset is a 23 mile 24” natural gas fuel line which connects multiple interstate pipelines to an industrial development outside Toledo, Ohio. AMP also owns and operates a 56-mile pipeline and right-of-way that provides access to the Leidy Storage field and multiple major interstate pipelines in north-central Pennsylvania located in the Marcellus Shale fairway.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2011-06-13 Sidewinder Drilling, Inc.

Houston, Texas, United States

Sidewinder is a land-based drilling contractor that utilizes a technologically advanced fleet of highly mobile, operationally flexible, ultra-efficient land drilling rigs to service exploration and production companies. Sidewinder Drilling was founded in 2011 and is based in Houston, Texas.

Buy -
SELLER

HarbourVest Partners

Boston, Massachusetts, United States

Investor Investor Investor Investor Investor

website


Category Private Equity Firm
Founded 1978
PE ASSETS 45.0B USD
SizeMega
Type Sector Agnostic
DESCRIPTION

HarbourVest Partners, LLC is an investment firm that makes investments in new private equity partnerships, acquires secondary interests, and makes direct investments in operating companies. HarbourVest's largest investment area is investments in private equity funds, comprising of approximately 2/3 of HarbourVest's assets. HarbourVest's direct investment group looks for investments in growth oriented businesses at a variety of stages. The Group generally targets co-investments of $5 to $100 million, growth capital financings of $5 to $40 million, or mezzanine commitments of $5 to $20 million. Sectors of interest include software, hardware, data communications, telecommunications, and financial services. HarbourVest was formed in 1997 to assume the business of Hancock Venture Partners which was formed in 1982. HarbourVest Partners is based in Boston, Massachusetts, with additional offices in London, Tokyo, and Hong Kong.


DEAL STATS #
Overall 24 of 103
Sector (Life Science) 2 of 4
Type (Add-on Acquisition) 7 of 45
Country (Switzerland) 1 of 1
Year (2011) 3 of 8
Size (of disclosed) 1 of 34
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-05-19 Roompot Vakanties BV

Goes, Netherlands

Roompot is a European holiday park operator active in the exploitation of holiday parks, tour operating services for third party holiday parks, and the development of holiday parks. Roompot was founded in 1965 and is based in Goes, Netherlands.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2011-05-26 FreeScale Semiconductor Ltd.

Austin, Texas, United States

Freescale Semiconductor, Inc. is a designer and manufacturer of embedded semiconductors for the automotive, consumer, industrial, networking and wireless markets. FreeScale designs, researches and development, manufacturing or sales operations in more than 30 countries.

Sell -
SELLER

Nordic Capital

Stockholm, Sweden

Investor Investor Investor Investor Investor

website


Category Private Equity Firm
Founded 1989
PE ASSETS 12.5B EUR
SizeMega
Type Sector Agnostic
DESCRIPTION

Nordic Capital is a private equity investment firm that targets middle-market company investments located in Scandinavia and Northern Europe. Nordic seeks investments across a wide range of industries and prefers situations where there are 'opportunities for new industrial combinations, strategic repositioning, international expansion and operational improvements'. Nordic Capital was formed in 1989 and has offices in Stockholm, Copenhagen, London, Oslo, and Helsinki.


DEAL STATS #
Overall 32 of 65
Sector (Life Science) 3 of 5
Type (Add-on Acquisition) 13 of 21
Country (Switzerland) 3 of 3
Year (2011) 2 of 5
Size (of disclosed) 1 of 16
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-04-28 Falck Holding A/S

Copenhagen, Denmark

Falck Holding A/S is a provider of rescue and safety courses. Falck’s activities are directed at preventing accidents and disease; providing assistance in situations of emergency, accidents and need; and helping people move on with their lives after illness or accidents.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2011-05-20 Bulten AB

Gothenburg, Sweden

Bulten is a supplier of fasteners to the European automotive industry. The company’s product range includes everything from customer-specific standard products to specialist, customized fasteners. The company also provides technical development, line-feeding, logistics, material and production expertise. Bulten offers a Full Service Provider concept or parts thereof. Bulten was founded in 1873 and is based in Gothenburg, Sweden.

Sell -